Skip to main content

Table 1 Characteristics of COAD patients

From: Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma

Characteristic

TCGA cohort

GSE40967 cohort

No.of patients

Percentage (%)

No.of patients

Percentage (%)

Age

 < 60

122

26.99

153

26.15

 ≥ 60

330

73.01

432

73.85

Gender

Male

238

52.65

322

55.04

Female

214

47.35

263

44.96

Clinical stage

I

76

16.81

42

7.18

II

178

39.39

271

46.32

III

125

27.65

210

35.90

IV

62

13.72

60

10.26

Unknown

11

2.43

2

0.34

T stage

T1

10

2.21

16

2.74

T2

77

17.04

49

8.38

T3

308

68.14

379

64.78

T4

57

12.61

119

20.34

Unknown

0

0

22

3.76

N stage

N0

269

59.51

314

53.68

N1

103

22.79

137

23.42

N2

80

17.70

106

18.12

Unknown

0

0

28

4.78

M stage

M0

334

73.89

499

85.30

M1

62

13.72

61

10.43

Mx

49

10.84

3

0.51

Unknown

7

1.55

22

3.76

Survival status

Alive

364

80.53

395

67.52

Dead

88

19.47

179

30.60

Unknown

0

0

11

1.88